Bioregen Pursues IPO Despite Mounting Skincare Losses
Medical device maker Bioregen is heading to an IPO on the Beijing Stock Exchange, but its fast-growing skincare brand VITREGEN remains unprofitable.
Archive
Medical device maker Bioregen is heading to an IPO on the Beijing Stock Exchange, but its fast-growing skincare brand VITREGEN remains unprofitable.
Chicana-owned beauty brand Nopalera has secured $4 million in Series A funding to expand its product lineup and scale retail partnerships, including an upcoming launch at Costco.
A breakthrough study published in Scientific Reports provides clinical-grade evidence that Suhua's macromolecular recombinant humanized collagen can actively penetrate the dermis, opening a new era of non-invasive...